SLC7A5 and steatosis: Analysis of HFD‐induced MASH indicated that E2F2M‐KO mice with SLC7A5 knockdown exhibited decreased steatosis, reduced inflammation, lower liver weights, and diminished serum liver enzyme levels, along with decreased hepatic TG content(Figure5A–F).